Market Overview

Benzinga's Top Pre-Market Gainers

Related GNOM
Benzinga Market Primer: Wednesday, March 13
BGI-Shenzhen Receives Approval from Ministry of Commerce of PRC for Proposed Acquisition Of Complete Genomics
Related MRK
Health Care And Biotech Sector Looking Sick
FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities
Making Money With Charles Payne: 12/8/14 (Fox Business)

Complete Genomics (NASDAQ: GNOM) surged 9.22% to $3.20 in the pre-market session. Complete Genomics announced new technology developed for clinical-grade genomes.

Merck & Co (NYSE: MRK) added 3.98% to $42.85 in the pre-market session. Analysts at Citigroup upgraded Merck from “neutral” to “buy.”

SunPower (NASDAQ: SPWR) moved up 1.52% to $4.67 in the pre-market session. Analysts at Piper Jaffray upgraded SunPower from “neutral” to “overweight.”

Ocean Power Technologies (NASDAQ: OPTT) soared 1.41% to $3.60 in the pre-market trading. Ocean Power Technologies and Lockheed Martin (NYSE: LMT) have entered into a teaming agreement to develop a 19 megawatt wave-energy project in Victoria, Australia.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (LMT + GNOM)

Around the Web, We're Loving...

Get Benzinga's Newsletters